Cheng Fang

Cheng Fang

Company: Annovis Bio

Job title: Senior Vice President, Research & Development

Seminars:

Translational Inhibition of Multiple Neurotoxic Proteins Leads to Improved Motor Function in Parkinson’s Disease 11:45 am

Parkinson’s disease has mixed pathology and proteinopathy Inhibiting multiple neurotoxic aggregating proteins together shows beneficial effects Buntanetap improved PD patient’s motor functionsRead more

day: Day Two Track B AM

Panel Discussion: Investigating Neuro-Regeneration & New Possibilities in Affecting Neuronal Damage 2:15 pm

How can disease endotypes be identified and drug treatments tailored in the face of developing markers and mechanistic understanding? Is a single target approach likely to be effective in most patients where the disease course is highly varied? What are the challenges and drawbacks of the polypharmacy multi-target methods in an aged population?Read more

day: Day Two

© Copyright 2022 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.